Gelonghui, August 27th, Dezhan Healthcare (000813.SZ) announced its 2024 interim report, with a revenue of 0.248 billion yuan during the reporting period, a 12.46% year-on-year growth; the net income attributable to the shareholders of the listed company was 10.1526 million yuan, turning losses into profits year-on-year; the net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 7.9021 million yuan; the basic earnings per share was 0.0047 yuan.
德展健康(000813.SZ)：上半年净利润1015.26万元 同比扭亏
Dezhan Healthcare (000813.SZ): The net income in the first half of the year was 10.1526 million yuan, a year-on-year recovery from losses.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.